Xelcis Bio

Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	867 Boylston St, Suite 500, Boston, Massachusetts 02116, US
Website	xelcisbio.com
NAICS	541714
Founded	2024
Employees	1-10

Key Contact at Xelcis Bio

Michael Dudley

CEO, Co-Founder

About Xelcis Bio

Xelcis Bio™ is pioneering a new era in targeted cancer therapeutics through our proprietary TRIDENT™ delivery platform. For our lead program, we combine cutting-edge nanoparticle technology with chemotherapy to create precisely targeted therapies that enhance effectiveness while reducing side effects. At Xelcis Bio™, we're not just improving existing treatments —we're transforming the way cancer care is delivered, with the goal of better outcomes and improved quality of life for patients worldwide.

Xelcis Bio revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Xelcis Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Xelcis Bio has never raised funding before.

Frequently asked questions

Xelcis Bio is located in Boston, Massachusetts, US.

Xelcis Bio was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Xelcis Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Xelcis Bio

Michael Dudley

CEO, Co-Founder

4.8

40,000 users